JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

JNJ

238.68

-0.55%↓

UNH

274.9

-0.55%↓

TMO

546.83

+0.89%↑

ABT

111.08

+0.23%↑

ISRG

492.83

+1.14%↑

Search

Prestige Consumer Healthcare

Slēgts

SektorsVeselības aprūpe

65.37 -1.4

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

64.4

Max

66.3

Galvenie mērījumi

By Trading Economics

Ienākumi

-5.3M

42M

Pārdošana

25M

274M

P/E

Sektora vidējais

16.198

84.243

Peļņas marža

15.399

Darbinieki

600

EBITDA

7.2M

87M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+14.58% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 7. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

239M

3.2B

Iepriekšējā atvēršanas cena

66.77

Iepriekšējā slēgšanas cena

65.37

Ziņu noskaņojums

By Acuity

8%

92%

7 / 352 Rangs Healthcare

Prestige Consumer Healthcare Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 9. febr. 17:25 UTC

Iegādes, apvienošanās, pārņemšana

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

2026. g. 9. febr. 23:46 UTC

Tirgus saruna

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

2026. g. 9. febr. 23:43 UTC

Tirgus saruna

Gold Falls on Possible Technical Correction -- Market Talk

2026. g. 9. febr. 23:14 UTC

Tirgus saruna

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

2026. g. 9. febr. 22:29 UTC

Tirgus saruna

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

2026. g. 9. febr. 22:19 UTC

Tirgus saruna

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

2026. g. 9. febr. 22:08 UTC

Tirgus saruna

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

2026. g. 9. febr. 22:01 UTC

Peļņas

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

2026. g. 9. febr. 21:59 UTC

Peļņas

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

2026. g. 9. febr. 21:59 UTC

Peļņas

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

2026. g. 9. febr. 21:58 UTC

Peļņas

Friedman Industries 3Q Sales $168M >FRD

2026. g. 9. febr. 21:50 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Financial Services Roundup: Market Talk

2026. g. 9. febr. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 9. febr. 21:48 UTC

Peļņas

Friedman Industries 3Q EPS 43c >FRD

2026. g. 9. febr. 21:17 UTC

Peļņas

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

2026. g. 9. febr. 21:13 UTC

Tirgus saruna

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

2026. g. 9. febr. 21:04 UTC

Peļņas

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

2026. g. 9. febr. 20:30 UTC

Tirgus saruna

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

2026. g. 9. febr. 20:02 UTC

Tirgus saruna

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

2026. g. 9. febr. 19:42 UTC

Tirgus saruna

Japan's Yield Curve Expected to Flatten -- Market Talk

2026. g. 9. febr. 19:31 UTC

Tirgus saruna

Nike Seen Regaining Relevance With Consumers -- Market Talk

2026. g. 9. febr. 19:27 UTC

Tirgus saruna

Gold Climbs Back Over $5,000/oz -- Market Talk

2026. g. 9. febr. 19:05 UTC

Tirgus saruna

Nike Returns to List of Hottest Brands -- Market Talk

2026. g. 9. febr. 18:19 UTC

Tirgus saruna

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

2026. g. 9. febr. 17:41 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

2026. g. 9. febr. 17:31 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

2026. g. 9. febr. 17:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Financial Services Roundup: Market Talk

2026. g. 9. febr. 17:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 9. febr. 17:17 UTC

Tirgus saruna

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

2026. g. 9. febr. 17:16 UTC

Peļņas

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Prestige Consumer Healthcare Prognoze

Cenas mērķis

By TipRanks

14.58% augšup

Prognoze 12 mēnešiem

Vidējais 76 USD  14.58%

Augstākais 86 USD

Zemākais 66 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Prestige Consumer Healthcare — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

3

Pirkt

1

Turēt

0

Pārdot

Noskaņojums

By Acuity

7 / 352 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
help-icon Live chat